Medical device quality systems experts from across the total product lifecycle are enthusiastic about the US Food and Drug Administration’s Case for Quality Voluntary Improvement Program (CfQVIP), or VIP for short.
VIP, which grew from the FDA’s Case for Quality Pilot, was finalized in a guidance document in September 2023. It’s an initiative from the FDA to implement proactive quality control...
Key takeaways:
-
The Voluntary Improvement Program (VIP) has decreased recalls and site inspections for participants.
-
VIP appraisals are different than audits and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?